Search Tag: neuropsychiatric disorder treatments

Executive Health Management

2024 21 Mar

  A seasoned pharmaceutical industry executive with over 40 years at the forefront of innovation, including at Synthelabo (acquired by Sanofi-Aventis), Dr. Angel aims to propel MIRA Pharmaceuticals' mission to tackle unmet needs in neurologic and neuropsychiatric disorders   MIRA Pharmaceuticals Inc., an innovative pre-clinical-stage pharmaceutical...Read more